BbCRASP-2 and Its Role in Lyme Disease
Author Information
Author(s): Coleman Adam S., Yang Xiuli, Kumar Manish, Zhang Xinyue, Promnares Kamoltip, Shroder Deborah, Kenedy Melisha R., Anderson John F., Akins Darrin R., Pal Utpal
Primary Institution: University of Maryland, College Park, Maryland, USA
Hypothesis
Is BbCRASP-2 essential for complement resistance or infectivity of Borrelia burgdorferi in murine hosts?
Conclusion
BbCRASP-2 is not essential for complement resistance or infectivity in mice.
Supporting Evidence
- B. burgdorferi BbCRASP-2 is expressed in murine tissues but not in ticks.
- Immunization with BbCRASP-2 did not protect mice from infection.
- B. burgdorferi BbCRASP-2 mutants retained full infectivity in mice.
- B. burgdorferi BbCRASP-2 mutants were resistant to complement-mediated killing in vitro.
Takeaway
The study found that a protein called BbCRASP-2 doesn't help the Lyme disease bacteria survive in the body or cause illness, even though it is present during infection.
Methodology
Mice were immunized with BbCRASP-2 and then infected with Borrelia burgdorferi to assess infection and immune response.
Limitations
The study only examined the role of BbCRASP-2 in a murine model and did not explore its effects in other hosts.
Participant Demographics
C3H/HeN mice, 4-6 weeks old.
Statistical Information
P-Value
p>0.05
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website